Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy

ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46497-46503. doi: 10.1021/acsami.9b16270. Epub 2019 Dec 3.

Abstract

A material that possesses high loading efficiency (in terms of delivering small molecular drugs, nucleic acids, peptides, and proteins) has various medical applications, such as in tumor diagnosis and gene therapy or chemotherapy of tumors. Mesoporous silica nanoparticles are ideal nanocarriers for constructing drug delivery systems because of the unique mesoporous channels for encapsulation and the sustainable release of anticancer drugs. Herein, we demonstrate a doxorubicin (DOX)-peptides double-loaded and -response nanodrug (DMK nanoplatforms) as a multifunctional nanoplatform for chemotherapy of tumors. The nanoparticles are prepared by a surface modification strategy. The KLAK and DOX release in an acidic/reductive tumor microenvironment, which efficiently penetrate cell nuclei and generate the antitumor effect. Our study provides a new approach for developing a smart drug delivery nanosystem, particularly for peptides-guided pH-sensitive chemotherapy.

Keywords: breast tumor; double-load and -response; drug delivery; mesoporous silica nanoparticles (MSNs); proapoptotic peptide.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology*
  • Drug Delivery Systems*
  • Drug Liberation
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Metal Nanoparticles / chemistry
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Porosity
  • Silicon Dioxide / chemistry
  • Silicon Dioxide / pharmacology
  • Tumor Microenvironment / drug effects

Substances

  • Antineoplastic Agents
  • Peptides
  • Silicon Dioxide
  • Doxorubicin